Skip to content

Rafael Holdings, Inc. RFL Inprocess Research And Development Noncurrent

Inprocess Research And Development Noncurrent at other companies

CTO
Citius Oncology, Inc.CTOR
$71.11M-3.1%
NuScale Power logo
NuScale PowerSMR
$16.9M0.0%
Savara logo
SavaraSVRA
$11.36M+5.9%
CTO
Citius Oncology, Inc.CTOR
$18.35M
UroGen Pharma logo
UroGen PharmaURGN
$0-100%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$21.73M+1,211%

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept rfl:InprocessResearchAndDevelopmentNoncurrent.

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s inprocess research and development noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s inprocess research and development noncurrent?
Rafael Holdings, Inc. (RFL) reported inprocess research and development noncurrent of $31.58M in Q1 2026.
How has Rafael Holdings, Inc.'s inprocess research and development noncurrent changed year-over-year?
Rafael Holdings, Inc.'s inprocess research and development noncurrent decreased by 0.0% year-over-year, from $31.58M to $31.58M.
What is the long-term trend for Rafael Holdings, Inc.'s inprocess research and development noncurrent?
Over 2 years (2023 to 2025), Rafael Holdings, Inc.'s inprocess research and development noncurrent has grown at a 347.7% compound annual growth rate (CAGR), from $1.58M to $31.58M.
What does inprocess research and development noncurrent mean?
This represents the capitalized value of research and development projects that are currently in progress and have not yet reached commercial viability. It reflects the intrinsic value of the company's pipeline and future growth potential. Investors track this to evaluate the scale and progress of the company's innovation efforts.